Apollo Endosurgery, Inc. (APEN) Stock Overview
Explore Apollo Endosurgery, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Apollo Endosurgery, Inc. (APEN)
Key Financials
Key Financials
Market Cap
579.7M
P/E Ratio
-10.20
EPS (TTM)
$-1.06
ROE
-0.85%
APEN Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Apollo Endosurgery, Inc. (NASDAQ: APEN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Apollo Endosurgery, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of APEN on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $16.11 for the NASDAQ listing.
Key metrics behind Apollo Endosurgery, Inc.'s NASDAQ-traded stock include a P/E ratio of -10.20 and a market capitalization of 579.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of APEN on the NASDAQ.